An army of digital health technologies like Artificial Intelligence (AI)-powered gadgets like digital stethoscope, electronic tattoos which monitor vitals, miniscule sensors, and smartwatches tracking heartbeats are quickly transforming the traditional preventive tools of Cardiovascular Disease (CVDs). Experts pronounce that digital platforms like augmented reality will break the barriers and change the scenario of cardiac care. Cardiology is changing to be more about prediction and early intervention than treating after it becomes a full-blown disease.
In India, around 65 percent of total deaths are due to NCDs, of which around 27 percent are attributed to CVDs. CVDs also account for 45 percent of deaths in the 40-69-year age group. They strike Indians a decade earlier than the western population. They also have the highest coronary artery disease (CAD) rates, inform experts. Cardiologists believe that digital platforms are rapidly transforming the scenario by making healthcare more personalized.
Regeneration of Heart Care in the Digital Age
Data from digital wearable allows more precise analysis of the risk factors with a detailed visual impression of an individuals health in real time, Dr Rahul Gupta, Consultant, Cardiology, Apollo Hospitals NaviMumbai, said, The trend over the years of health markers such as blood sugar, cholesterol levels, etc. can give a real-time visual impression on the deterioration or improvement of the health status of an individual. Some platforms also help in tracking the diet with calories consumed and steps to be taken to burn them. The health technology solutions are designed and built on real-world data. Encryption technology ensures the security of data and legal provisions regarding privacy of data are very stringent.
Commenting that innovation in smart diagnostic solutions for cardiac care is the new normal, Nitin Stephen Abel, Business Marketing and Sales Leader, Image Guided Therapy, Philips Indian Subcontinent, said, We are integrating different types of patient data at the (cath-lab) tableside to help interventional cardiologists decide, guide, treat, and confirm successful procedural and clinical outcomes. And we are also doubling down on our efforts to connect cardiac care teams to patients at home.
As per Philips flagship Future Health Index India 2021 report, Indian healthcare leaders appear to be adopting a three-step approach to achieve digital transformation in healthcare. The pillars of this approach include, investing in telehealth in the short term to ensure access to care and future investment in AI to drive operational efficiencies and partnerships with other hospitals or healthcare facilities to facilitate the use of these technologies.
Giving details about mobile devices, including smartphones or other wearable technology, with embedded sensors and AI, that will play an instrumental role in measuring and promoting physical activity and fitness, Abhishek Bhargava, Director, Cardiac Rhythm Management, Cardiac Ablation and Diagnostics, Medtronic India, said, Digital health technology promises to revolutionize healthcare as we know it today. AI, for instance, can substantially help develop further sophistication at every step in cardiac care, including research and discovery, diagnosis, and selection of appropriate therapy. Besides enhancing patient care, it can also streamline, accelerate, and optimize clinical research operations and reduce costs. Clinical visits and short-term monitoring have typically been insufficient in detecting issues, but the possibility of ongoing monitoring by mobile devices can help prevent strokes, manage symptoms, reduce hospitalizations and improve survival.
Experts mention the new-edge technologies like bluetooth-enabled cardiac devices, AI, advanced algorithms and predictive analytics, and remote connected care enable remote cardiac monitoring, quicker decision making, faster time to treatment, reduce time spent in the hospital, and lead to a potential increase in patient survival rates. They point that COVID-19 has leapfrogged the usage of technology to a new level and opened opportunities for making better use of data.
Informing that pandemic has helped the patients, healthcare practitioners realize and maximize the arising digital and data opportunities in heart care. COVIDs Big Impact on Cardiac Care
COVID had a detrimental effect with an increased number of cardiac diseases in India. The pandemic-induced lockdowns led to a change in lifestyle, especially with respect to sleep and eating patterns leading to obesity, high blood sugar and hypertension, which are all directly proportional to the increased risk of cardiovascular diseases (CVDs). At the same time, a major change that was observed during the pandemic was the growing adoption of digital technology to access healthcare. It will be fair to say that the integration of digital technology in the pandemic policy was a striking feature to curb the pandemic growth and keep the mortality low.
During the first wave, the focus was on COVID. Due to fear of infection, people stopped visiting hospitals and this led to the existing chronic conditions and NCDs being neglected. Since heart disease grows silently, the complications are visible and symptoms start reflecting only when it is advanced. However, the period also saw a rapid growth in telemedicine, online consultations, digital health apps and patient-monitoring devices which helped in providing real-time data and led to continuity of care for many patients with NCDs. Without digital health, the situation would have been much worse, Gupta added.
According to a report published by Invest India in 2021, India's medical equipment market is anticipated to be approximately $10 billion. The cardiac care industry has a large population base, so there is still a lot of room for growth, and technological advancements are likely to help. The India Cardiovascular Devices Market is growing at a CAGR of 5.9 per cent over the next five years (2021-2026), as per Mordor Intelligence report
During the COVID-19 epidemic, telemedicine has progressed. Outpatient Departments (OPDs) and follow-ups in cardiac care have transitioned to telemedicine, just like any other specialty, with patients using telephonic or video conferencing services. A patient is only admitted to the hospital if a procedure (tertiary care) is required after a thorough examination of symptoms. The COVID-19 pandemic's global expansion has increased the adoption and acceptance of remote monitoring and other digital approaches to cardiovascular disease therapy, Mishra added.
Mishra, further listing out the latest technologies, stated that AI, blockchain, Alexa capabilities, and chatbots are some of the new cardiac technologies that doctors are exploring right now. Technologies like Amplatzer Piccolo Occluder in India is the world's first medical device for treating patent ductus arteriosus, or PDA, that can be implanted in the youngest babies (weighing as low as 700 gms) via a minimally invasive process. Another invocation is the clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. The clip device repairs leaky mitral valves without open-heart surgery and is delivered to the heart through a vein in the leg. Recently implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices were introduced in India by Abbott, which brought the most advanced heart rhythm management capabilities. There are several new introductions of technologies in the field of cardiovascular treatments.
Although, the adoption of digital technologies in healthcare is encouraging, challenges with data management (65 percent) and lack of its interoperability across the technological systems (55 percent), are seen as the top barriers for a seamless workflow and superior patient experience, indicates Future Health Index India 2021 report.
Experts cite that though digital health comes with a plethora of benefits, major challenges that tend to hinder its widespread adoption include concerns over data quality and robustness, patient safety and privacy, ease of use, and accessibility.
Digital Interventions to foster Cardiac Care Outcomes
The medical device companies and cardiologists are affirmative that digital health interventions can reduce cardiovascular disease outcomes and improve some risk factors for cardiovascular disease.
If it is hospital or home healthcare delivery anytime, anywhere is the ultimate health management goal, on the cardiac front- using the digital streams -- we should be able to see improvements in the patient pathway, upgrades in diagnostic, interventional procedures and the emergence of telehealth for monitoring patients remotely. Cardiac patients access will be simplified using digital platforms through mobile phones i.e. from calling an ambulance on time, to sharing updated patient records immediately or to evaluating clinical options with multiple sources, there would be more and more options all centred around the patient, Abel added.
Experts foresee that on cardiac diagnostics and interventions, front procedures have been done without X-rays building on digital strengths or integrating VR with 3D-coloured augmented images to do procedures in a more predictable way. The current AI-enabled clinical applications being a more routine way to decide, guide and treat everyday clinical procedures. Wearables and mobile phones will continue to become more sophisticated in the way telehealth is managed. Future technologies are on the brink of a revolution, as India Cardiovascular Devices Market is thinking beyond the realm of current possibility, life-changing smart innovations in cardiac care are on the horizon.
Read more:
Breaking Barriers: Cardiac Care is transcending to a digital future - ETHealthworld.com
- Cardiac Regeneration - Center for Regenerative Medicine - Mayo Clinic ... - April 11th, 2018 [April 11th, 2018]
- Cardiac Regeneration - Mayo Clinic - April 22nd, 2018 [April 22nd, 2018]
- Materials - MDPI - May 18th, 2018 [May 18th, 2018]
- Cardiac Stem Cell Research - Cedars-Sinai - May 22nd, 2018 [May 22nd, 2018]
- Cardiac regeneration: current therapiesfuture concepts ... - May 26th, 2018 [May 26th, 2018]
- Cardiac Regeneration - Victor Chang Cardiac Research Institute - May 30th, 2018 [May 30th, 2018]
- Cardiology Conferences | Cardio 2018 Events | Cardiac ... - June 6th, 2018 [June 6th, 2018]
- Laboratory for Cardiac Regeneration | Baylor College of ... - June 18th, 2018 [June 18th, 2018]
- Regeneration of Muscle - July 8th, 2018 [July 8th, 2018]
- Regeneration of Muscle - eLS: Essential for Life Science - July 14th, 2018 [July 14th, 2018]
- Cardiac Repair and Regeneration Research Unit | Heart and ... - July 25th, 2018 [July 25th, 2018]
- Myogenesis - Wikipedia - August 8th, 2018 [August 8th, 2018]
- Regeneration (biology) - Wikipedia - August 21st, 2018 [August 21st, 2018]
- World Cardiology and Cardiologist Meeting - August 21st, 2018 [August 21st, 2018]
- Cardiac (comics) - Wikipedia - August 26th, 2018 [August 26th, 2018]
- Cardiac regeneration and repair - 1st Edition - Elsevier - September 21st, 2018 [September 21st, 2018]
- Post-doc position available cardiac regeneration ... - September 29th, 2018 [September 29th, 2018]
- UW Bioengineering: Building World Leadership in Heart ... - September 29th, 2018 [September 29th, 2018]
- Cardiac Regeneration - What Science Can Do - AstraZeneca - October 2nd, 2018 [October 2nd, 2018]
- Cardiac Regeneration, Stem Cells | Research | Baylor ... - November 30th, 2018 [November 30th, 2018]
- Cardiac Regeneration - Victor Chang Institute - December 6th, 2018 [December 6th, 2018]
- Entering a new era in vascular and cardiac regeneration ... - December 19th, 2018 [December 19th, 2018]
- Cardiac regeneration and repair - 1st Edition - December 19th, 2018 [December 19th, 2018]
- Heart Regeneration Technologies - December 19th, 2018 [December 19th, 2018]
- Cardiac Regeneration - Center for Regenerative Medicine ... - December 19th, 2018 [December 19th, 2018]
- Zebrafish Heart Regeneration | HHMI BioInteractive - December 22nd, 2018 [December 22nd, 2018]
- Rapid cell regeneration - Heroes Wiki - December 22nd, 2018 [December 22nd, 2018]
- Cardiac muscle - Wikipedia - December 23rd, 2018 [December 23rd, 2018]
- Cardiac regeneration in and : discrepancies and problems ... - January 8th, 2019 [January 8th, 2019]
- OHSU Center for Regenerative Medicine Heart Regeneration ... - January 8th, 2019 [January 8th, 2019]
- Dr. Sanjiv Dhingra, Cardiac Regeneration and Tissue ... - January 30th, 2019 [January 30th, 2019]
- Mending a Broken Heart: Stem Cells and Cardiac Repair ... - February 20th, 2019 [February 20th, 2019]
- Cardiac Repair and Regeneration | Division of Cardiology ... - February 20th, 2019 [February 20th, 2019]
- Stem Cell Therapy and Stem Cell Injection Provider Finder ... - March 5th, 2019 [March 5th, 2019]
- KearnsSayre syndrome - Wikipedia - March 8th, 2019 [March 8th, 2019]
- Ruohola-Baker Lab - March 15th, 2019 [March 15th, 2019]
- MTS Science - May 3rd, 2019 [May 3rd, 2019]
- New Insights Into the Healing Capacity of the Heart: The Hippo Pathway - Cath Lab Digest - September 26th, 2019 [September 26th, 2019]
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances - September 29th, 2019 [September 29th, 2019]
- The nanoengineer working to mend broken hearts - UNSW Newsroom - September 29th, 2019 [September 29th, 2019]
- New insights into heart's healing capacity - Baylor College of Medicine News - September 29th, 2019 [September 29th, 2019]
- Tenaya Therapeutics Closes $92 Million Series B Financing - BioSpace - October 5th, 2019 [October 5th, 2019]
- Regenerative medicine today: Are diabetes and vascular disease treatments ready for the clinic? - Science Magazine - October 5th, 2019 [October 5th, 2019]
- Reviewing resTORbio Inc. (TORC)'s and Anika Therapeutics Inc. (NASDAQ:ANIK)'s results - MS Wkly - October 14th, 2019 [October 14th, 2019]
- TAMassociati: the new Church of the Resurrection in Varignano - Floornature.com - October 14th, 2019 [October 14th, 2019]
- What the Hippo pathway in cardiac fibroblasts reveals about heart function - Baylor College of Medicine News - October 19th, 2019 [October 19th, 2019]
- Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy (DMD) - BioSpace - October 22nd, 2019 [October 22nd, 2019]
- Regenerative Medicine Market Industry Outlook, Growth Prospects and Key Opportunities - Health News Office - October 24th, 2019 [October 24th, 2019]
- Ottawa-based treatment a leap forward in addressing heart failure - Winnipeg Sun - October 27th, 2019 [October 27th, 2019]
- Global Regenerative Medicines Market Demand Analysis & Opportunity Evaluation Report 2019-2027 with Focus on U.S. & Europe -... - November 15th, 2019 [November 15th, 2019]
- The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure - Physician's Weekly - November 15th, 2019 [November 15th, 2019]
- SANUWAVE Health Reports Third Quarter 2019 Financial Results Other OTC:SNWV - GlobeNewswire - November 16th, 2019 [November 16th, 2019]
- Moderna: Undervalued As The Promising Pipeline Awaits Collaborations - Seeking Alpha - November 23rd, 2019 [November 23rd, 2019]
- Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells Derived from Adipose Tissue and Bone Marrow on Acute Myocardial Infarction... - November 23rd, 2019 [November 23rd, 2019]
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania - December 5th, 2019 [December 5th, 2019]
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace - December 9th, 2019 [December 9th, 2019]
- Polymeric Biomaterials Market Trends Analysis Forecast to 2019-2024 |Evolving Industry Overview by Types, Applications, Size & Share - Sino News... - December 16th, 2019 [December 16th, 2019]
- SMD - Researchers look behind the biological curtain on how fish oil might fight inflammatory disease - QMUL - December 16th, 2019 [December 16th, 2019]
- Suspended animation, you say? The biggest and freakiest scientific breakthroughs of 2019 - SYFY WIRE - December 29th, 2019 [December 29th, 2019]
- 2019: Year in Pictures by Robert Cohen | Metro - STLtoday.com - December 31st, 2019 [December 31st, 2019]
- MicroCures Announces Issuance of New Patent Covering First-of-its-Kind Cell Movement Decelerator Technology with Potential Applications in Oncology... - January 15th, 2020 [January 15th, 2020]
- Cells that regenerate heart in zebrafish discovered - Biology Reporter - February 7th, 2020 [February 7th, 2020]
- SANUWAVE Health Appoints Dr. Tom Price to Its Board of Directors - Yahoo Finance - February 7th, 2020 [February 7th, 2020]
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - Associated Press - March 19th, 2020 [March 19th, 2020]
- Researchers and Doctors alike pursuing the field of stem cell research in treating heart attack survivors - Medical Herald - March 19th, 2020 [March 19th, 2020]
- Artificial Heart Lung Machines Market report reviews opportunities and analysis by size, share, trends, manufacturer, forecast 2020-2026 - WhaTech... - April 29th, 2020 [April 29th, 2020]
- Scientists have figured out how to make the heart to regenerate - The Times Hub - April 29th, 2020 [April 29th, 2020]
- Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat dietinduced obesity - Science Advances - May 9th, 2020 [May 9th, 2020]
- SANUWAVE HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com - May 15th, 2020 [May 15th, 2020]
- SANUWAVE Health to Hold First Quarter Financial Results and Business Update Call on Monday, May 18, 2020 - Yahoo Finance - May 15th, 2020 [May 15th, 2020]
- SANUWAVE Health to Hold Investor Live Webcast on Wednesday, June 10, 2020 - Yahoo Finance - June 10th, 2020 [June 10th, 2020]
- SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity's UltraMIST and Exclusive Partnership Rights for Wound Care Biologic... - June 11th, 2020 [June 11th, 2020]
- SANUWAVE Health, Inc. Discusses The Potential of Their Celularity Acquisition with The Stock Day Podcast (SNWV) July 1, 2020 - Stock Day Media - July 1st, 2020 [July 1st, 2020]
- Interim Analysis of Recardio's Phase II Clinical Trial to Be Presented at the 2020 Congress of the European Society of Cardiology - PRNewswire - July 1st, 2020 [July 1st, 2020]
- Growth and demand of Plasma Therapy in the Asia Pacific Region available in the latest report - WhaTech Technology and Markets News - July 4th, 2020 [July 4th, 2020]
- Plasma Therapy Market Size by Top Companies, Regions, Types and Application, End Users and Forecast to 2027 - Bulletin Line - August 14th, 2020 [August 14th, 2020]
- Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen for Vascular Repair - BioSpace - August 14th, 2020 [August 14th, 2020]
- Polymeric Biomaterials Market Insights by Current Trends 2020 Future Demand by Top Key Players, Regions, Industry Size, and Business Strategy... - September 11th, 2020 [September 11th, 2020]
- CORRECTION - SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE From Largest Medicare and Medicaid Administrator in U.S. - Stockhouse - September 11th, 2020 [September 11th, 2020]
- New Research Paper Suggests RegeneRx's Thymosin Beta 4 May be Useful in Treating COVID-19 - PRNewswire - September 11th, 2020 [September 11th, 2020]